Medtide, Inc. is a public biotech or pharmaceutical company listed on HKEX under the ticker 3880, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest Medtide news
We have not published a story on Medtide yet. When there is news, it will appear here.
Questions about Medtide
What is the ticker symbol of Medtide?
Medtide, Inc. trades under the ticker 3880 on HKEX.
Where is Medtide listed?
Medtide, Inc. is listed on HKEX.
Which country or territory is Medtide listed under?
Our directory records Medtide, Inc. under China.
What does Medtide do?
Our directory classifies Medtide, Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline.
What is the ISIN of Medtide?
The ISIN recorded for Medtide, Inc. is CNE100006S86.
Does aibio.space cover Medtide?
aibio.space lists Medtide, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
Which companies are similar to Medtide?
Companies in our directory listed in the same country and business area as Medtide: Chongqing Zhifei Biological Products Co., Alphamab Oncology, Anhui Wanbang Pharmaceutical Technology Co., Zhuhai Trinomab Pharmaceutical Co., Shanghai Shen Lian Biomedical, Chengdu Olymvax Biopharmaceuticals.
Investor discussion: Medtide
Members talk about Medtide (3880). Reader posts, not aibio.space reporting, and not investment advice.
Rules
Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.
Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.
Capital-markets timeline
Financings, listing notices, splits, legal actions and other investor events at Medtide, newest first. Each line links the filing it comes from.
Mergers
Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION IN RELATION TO
THE CONSTRUCTION OF ROCKLIN SITE. Source
Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:3880 on TradingView.
Listing details
Medtide, Inc. is a public biotech or pharmaceutical company listed on HKEX under the ticker 3880, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.
Published and maintained by aibio.space. Not investment advice. How we work.
Who manages this pageThis page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio